In addition, we chose to study two major epigenetic regulators, DNMT1 (DNA methyltransferase 1) and EZH2 (enhancer of zeste homologue 2), since high levels of expression have been associated to melanoma aggressiveness [35]. The gene discussed is EZH2; the disease is melanoma.